about
Synthesis of copper and zinc 2-(pyridin-2-yl)imidazo[1,2-a]pyridine complexes and their potential anticancer activity.Bis(2-methyl-4-nitro-anilinium) tetra-chloridomercurate(II).Redetermination of the salt hexa-methyl-ene-tetra-minium fumarate.rac-(rel-1R,2R,4S)-Spiro-[bicyclo-[2.2.1]heptane-2,3'-indol]-2'-amine.Isonicotinamide-2-naphthoic acid (1/1).Form II of adipic acid-nicotinohydrazide (1/2).Benzoic acid-3,4-bis-[(pyridin-3-ylmeth-yl)amino]-cyclo-but-3-ene-1,2-dione (1/2)3-Bromo-pyridin-2-amineN'-Cyclo-dodecyl-idene-pyridine-4-carbohydrazide.Cyclo-propylammonium 4-iodo-benzoate6-Amino-nicotinamideBis-(2-hy-droxy-eth-yl)ammonium 2-bromo-phenolate.(±)-(rel-3R,3'R)-1,1'-Dimethyl-3,3'-bipyrrolidine-2,2'-dithione4-Amino-pyridinium 2-chloro-4-nitro-benzoate monohydrateAcridine 0.75-hydrateSynthesis, characterization and phase transitions of the inorganic-organic layered perovskite-type hybrids [(C(n)H(2n+1)NH3)2PbI4], n = 7, 8, 9 and 10.Synthesis, characterization, and molecular modeling of a pharmaceutical co-crystal: (2-chloro-4-nitrobenzoic acid):(nicotinamide).Bis(pentane-1,5-diammonium) decaiodotriplumbate(II).The hydrogen-bonding patterns of 3-phenylpropylammonium benzoate and 3-phenylpropylammonium 3-iodobenzoate: generation of chiral crystals from achiral molecules.Chiral carboxylic acids and their effects on melting-point behaviour in co-crystals with isonicotinamide.Hydrogen bonding in isomorphous 2-methyl-4-nitroanilinium bromide and iodide.Bis(4-aminopyridinium) hexachloridostannate(IV) and bis(p-toluidinium) hexachloridostannate(IV).Hydrogen-bonding one-dimensional chains containing the R4(2)(8) motif in the ammonium salts 1-naphthylammonium iodide and naphthalene-1,8-diyldiammonium diiodide.Formation of isostructural solid solutions in 2,6-disubstituted N-phenylformamides and N-phenylthioamides.A tale of two polymorphic pharmaceuticals: pyrithyldione and propyphenazone and their 1937 co-crystal patent.catena-Poly[bis(tert-butylammonium) [plumbate(II)-tri-mu-iodo] iodide dihydrate].Synthesis, characterization and phase transitions in the inorganic-organic layered perovskite-type hybrids [(CnH2n+1NH3)2PbI4], n = 4, 5 and 6.Prevalent polymorphism in benzophenones.A structural study of 4-aminoantipyrine and six of its Schiff base derivatives.An investigation to elucidate the factors dictating the crystal structure of seven ammonium carboxyl-ate mol-ecular salts.Binary and ternary charge-transfer complexes using 1,3,5-tri-nitro-benzene.Crystal structure of bromido(η6-1-isopropyl-4-methylbenzene)(7-oxocyclohepta-1,3,5-trien-1-olato-κ2O,O')osmium.Novel methodology for the synthesis of the benzo[b]phenanthridine and 6H-dibenzo[c,h]chromen-6-one skeletons. Reactions of 2-naphthylbenzylamines and 2-naphthylbenzyl alcoholsSupramolecular polymorphism of the 1 : 1 molecular salt (adamantane-1-carboxylate-3,5,7-tricarboxylic acid)·(hexamethylenetetraminium). A “failed” crystal engineering attemptPharmaceutical Co-crystals with Isonicotinamide—Vitamin B3, Clofibric Acid, and Diclofenac—and Two Isonicotinamide HydratesIncorporating active pharmaceutical ingredients into a molecular salt using a chiral counterionCentrosymmetric and NoncentrosymmetricR44(12) Rings As Primary Motifs in Salts of Sulfonate Anions and Chiral Primary Ammonium Cations: Their Occurrence in Hydrates, Nonhydrates, and the Zöllner IllusionConcomitant Polymorphs of the Antihyperlipoproteinemic BezafibrateDisruption of a robust supramolecular heterosynthon in achiral benzylammonium and (pyridylmethyl)ammonium m-iodobenzoate saltsRobust Supramolecular Heterosynthons in Chiral Ammonium Carboxylate Salts
P50
Q32184433-DCCD80EA-F151-4E88-82B8-2E8875D92FD3Q34225402-063F5F57-5416-4C1F-84E5-8095017E2287Q34630988-BD762EC8-BBA3-4C64-8DC2-5A0B05D849C6Q34636903-98234CD4-D2BF-467B-A67F-B4BF4A076922Q35616811-1E52E223-7274-44B2-AE24-0089BE47E180Q35662808-EAC8AAC0-B3B3-4DC3-BB23-E477A518199EQ35743749-AD95E486-9DEF-4AA5-AA48-C9CE52441BE5Q35743752-0D28E053-F0B0-43EB-B479-42ED9950CBD4Q35933680-7896D8BD-E3BE-450A-8598-4EA4A404C090Q36087453-1FC648E0-C629-4862-94D5-35DC9D5AA06CQ36149135-61E8F4AC-FBBD-499C-9BCB-ADD3C7BAD770Q36214113-B148C873-ECCC-4948-8C0F-1B5C2D76965BQ36448053-6CC55513-9910-479C-80A3-64FCE114FDD2Q36658671-5EC26F3C-6F4B-4811-93C5-D443E2AEA793Q38825103-DCE3183D-AA7B-4897-8687-FB6F3FF69803Q39716185-F43419AE-41E9-4355-89D7-46B0CA4CEE49Q43006894-502224F3-2323-445F-B3A7-66E84E5725B2Q44886792-4226DB1C-4251-4F65-AF18-5D090DDA0E8AQ46213757-2DFA38B2-F106-44F3-8FCC-50033BAFB087Q46231113-FDAC7176-D417-466A-80A6-BF14B3A7D03FQ46268020-794BBB6C-1F54-4FB4-936D-46901C8B5B60Q46325234-07B167FB-F4DA-497C-80D8-34FEB00F0E74Q46403332-C8F8A7BF-0054-4D98-9825-66BEE46932F1Q46685426-589ABEE1-71D0-4092-809A-B91C55E5F44EQ46768022-8C49634E-7432-4C6C-877E-F7A911319074Q46813507-A54246CB-8A5F-4BF7-A0F3-E1DA680DE90CQ50676526-32950B04-B926-49C9-AEEB-F0C1235DDF7AQ53695663-04EA6AFB-6F9D-438E-8A52-F04BD091D48CQ53810055-C30C72DF-A58A-40F1-8CFB-BDB5C0D9F190Q54963501-E94D44BB-A1E8-4884-9C96-D07B68082FD8Q55028143-81193D37-D91D-434B-B5D0-5B54378D77E9Q55040686-49DD66CD-E081-448A-A0F9-328E44B5CFD7Q57007255-EE06378B-FCDC-4541-A03D-04BF64D51216Q60206416-C8A4E88A-92CF-485F-B264-B76EE135A907Q60431173-77CFF888-1BCA-4A24-979B-D55121CF5D70Q60431184-B134C6C2-149E-4B70-A4D0-FFDFD8AF05CDQ60431193-453ABC71-545B-4B8E-AB04-DC6EBC425500Q60431195-B3C8F0DC-76CB-427C-BF4E-18D3E285EB90Q60431208-5C176F73-8DA5-4292-BAA5-F777534429DFQ60431211-AEED576F-A9CD-4DB9-8125-2B10654916D1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andreas Lemmerer
@ast
Andreas Lemmerer
@en
Andreas Lemmerer
@es
Andreas Lemmerer
@nl
type
label
Andreas Lemmerer
@ast
Andreas Lemmerer
@en
Andreas Lemmerer
@es
Andreas Lemmerer
@nl
prefLabel
Andreas Lemmerer
@ast
Andreas Lemmerer
@en
Andreas Lemmerer
@es
Andreas Lemmerer
@nl
P106
P1153
6504312853
P1960
1lfaquYAAAAJ
P21
P31
P496
0000-0003-1569-2831